Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Impact of Double Expression of MYC and BCL-2 on Outcomes in Primary CNS Lymphoma: A UK Multicentre Analysis

Blood (2022) 140 (Supplement 1): 372–374.

https://doi.org/10.1182/blood-2022-157699

Published: 2022

Journal Articles

Anti-CD21 Chimeric Antigen Receptor (CAR)-T Cells for T Cell Acute Lymphoblastic Leukaemia (T-ALL)

Nicola C Maciocia, Amy Burley, Francesco Nannini, Patrycja Wawrzyniecka, Margarida Neves, Thaneswari Karpanasamy, Mathieu Ferrari, Teresa Marafioti, Shimobi Onuoha, Asim Khwaja, Paul M Maciocia, Martin Pule

Blood (2021) 138 (Supplement 1): 902.

https://doi.org/10.1182/blood-2021-145725

Published: 2021

Journal Articles

Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress

Blood (2019) 134 (17): 1415–1429.

https://doi.org/10.1182/blood.2019001398

Published: 2019

Includes: Supplemental data

Journal Articles

Analysis of T-Cell Receptor Beta-Constant Region Expression for Rapid Assessment of T-Cell Clonality

Paul Maciocia, BSc, MBChB, MRCP, Margarida Neves, MSc, Shimobi Onuoha, PhD, Patrycja Wawrzyniecka, Giuseppe Gritti, Manuela Tosi, Alessia Moioli, Martin Pule, MD, Teresa Marafioti, MD

Blood (2018) 132 (Supplement 1): 2867.

https://doi.org/10.1182/blood-2018-99-112569

Published: 2018

Journal Articles

Cytotoxic CD4+ Cells in Chronic Lymphocytic Leukaemia: An Extended Immunophenotypic Analysis Examining Their Association with Cytomegalovirus Serostatus and Similarities with Cytotoxic CD8+ Cells

Maria A V Marzolini, Ayse Akarca, Karen Teng, Teresa Marafioti, MD, Satyen H Gohil, Amit C Nathwani, MD PhD, Evan Newell, PhD, Sergio A Quezada, Karl S Peggs

Blood (2018) 132 (Supplement 1): 3130.

https://doi.org/10.1182/blood-2018-99-116798

Published: 2018

Journal Articles

Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial

Blood (2018) 132 (Supplement 1): 1627.

https://doi.org/10.1182/blood-2018-99-118204

Published: 2018

Journal Articles

ADCT-402, a PBD dimer–containing antibody drug conjugate targeting CD19-expressing malignancies

Francesca Zammarchi, Simon Corbett, Lauren Adams, Peter C. Tyrer, Konstantinos Kiakos, Narinder Janghra, Teresa Marafioti, Charles E. Britten, Carin E. G. Havenith, Simon Chivers, Francois D’Hooge, David G. Williams, Arnaud Tiberghien, Philip W. Howard, John A. Hartley, Patrick H. van Berkel

Blood (2018) 131 (10): 1094–1105.

https://doi.org/10.1182/blood-2017-10-813493

Published: 2018

Includes: Supplemental data

Journal Articles

Acute Lymphoblastic Leukaemia (ALL) Cells and Commonly-Used Chemotherapy Drugs Can Induce Bone Marrow-Derived Mesenchymal Stromal Cells to Become Cancer Associated Fibroblasts (CAF), Leading to Enhanced ALL Proliferation and Treatment Resistance

Richard J Burt, MBBS, Aditi Dey, PhD, Kenton Cheuk Yan Ng, BSc, Bingjie Liu, MSc, Teresa Marafioti, MD, Erik Sahai, PhD, Adele K Fielding, MBBS,PhDFRCP,FRCPath

Blood (2017) 130 (Supplement 1): 1165.

https://doi.org/10.1182/blood.V130.Suppl_1.1165.1165

Published: 2017

Journal Articles

Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation

Janine Schmidt, Joan Enric Ramis-Zaldivar, Ferran Nadeu, Blanca Gonzalez-Farre, Alba Navarro, Caoimhe Egan, Ivonne Aidee Montes-Mojarro, Teresa Marafioti, Jose Cabeçadas, Jon van der Walt, Stefan Dojcinov, Andreas Rosenwald, German Ott, Irina Bonzheim, Falko Fend, Elias Campo, Elaine S. Jaffe, Itziar Salaverria, Leticia Quintanilla-Martinez

Blood (2017) 130 (3): 323–327.

https://doi.org/10.1182/blood-2017-03-776278

Published: 2017

Includes: Supplemental data

Journal Articles

Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA

Blood (2017) 129 (23): 3126–3129.

https://doi.org/10.1182/blood-2016-06-721712

Published: 2017

Includes: Supplemental data

Journal Articles

VEGFA- a New Therapeutic Target in CNS Leukemia

Blood (2016) 128 (22): 911.

https://doi.org/10.1182/blood.V128.22.911.911

Published: 2016

Journal Articles

Targeting T-Cell Receptor β-Constant Domain for Immunotherapy of T-Cell Malignancies

Paul Michael Maciocia, BSc,MBBS,MRCP, Patrycja Wawrzyniecka, MSc, Brian Philip, PhD, Ida Ricciardelli, PhD, Ayse U. Akarca, BSc, Shimobi Onuoha, PhD, David Cole, PhD, Andrew Sewell, PhD, Karl S Peggs, MD, David C. Linch, MD MRCP, MB BCh, BA, Teresa Marafioti, MD, Martin A Pule, MD PhD

Blood (2016) 128 (22): 811.

https://doi.org/10.1182/blood.V128.22.811.811

Published: 2016

Journal Articles

Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene

Blood (2016) 128 (8): 1101–1111.

https://doi.org/10.1182/blood-2016-03-703819

Published: 2016

Includes: Supplemental data

Journal Articles

Mechanistic and Pharmacodynamic Studies of Adct-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies

Michael J. Flynn, MD, Patrick H. van Berkel, PhD, Francesca Zammarchi, PhD, Peter C. Tyrer, PhD, Ayse U. Akarca, Narinder Janghra, Vishvesh Shende, PhD, Joseph Linares, Teresa Marafioti, MD, David G. Williams, PhD, Philip W. Howard, PhD, John A. Hartley, PhD

Blood (2015) 126 (23): 1559.

https://doi.org/10.1182/blood.V126.23.1559.1559

Published: 2015

Journal Articles

A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy

Brian Philip, Evangelia Kokalaki, Leila Mekkaoui, Simon Thomas, Karin Straathof, Barry Flutter, Virna Marin, Teresa Marafioti, Ronjon Chakraverty, David Linch, Sergio A. Quezada, Karl S. Peggs, Martin Pule

Blood (2014) 124 (8): 1277–1287.

https://doi.org/10.1182/blood-2014-01-545020

Published: 2014

Includes: Supplemental data

Journal Articles

The Ataxia Telangiectasia Nude Mouse with No Risk of Thymoma: A Model to Investigate Tumour Development of B Cell and Myeloid Origin Associated with ATM Loss

Tatjana Stankovic, MD, PhD, Phil Byrd, Tegan Francis, Teresa Marafioti, Zbigniew Rudzki, Alexander MR Taylor

Blood (2012) 120 (21): 1320.

https://doi.org/10.1182/blood.V120.21.1320.1320

Published: 2012

Journal Articles

Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets

Marion Travert, Yenlin Huang, Laurence de Leval, Nadine Martin-Garcia, Marie-Helene Delfau-Larue, Françoise Berger, Jacques Bosq, Josette Brière, Jean Soulier, Elizabeth MacIntyre, Teresa Marafioti, Aurélien de Reyniès, Philippe Gaulard

Blood (2012) 119 (24): 5795–5806.

https://doi.org/10.1182/blood-2011-12-396150

Published: 2012

Includes: Supplemental data

Journal Articles

Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS

Qian Zhang, HongYi Wang, Kanchan Kantekure, Jennifer C. Paterson, Xiaobin Liu, Andras Schaffer, Chrystal Paulos, Michael C. Milone, Niels Odum, Suzanne Turner, Teresa Marafioti, Mariusz A. Wasik

Blood (2011) 118 (11): 3062–3071.

https://doi.org/10.1182/blood-2011-01-332916

Published: 2011

Includes: Supplemental data

Journal Articles

APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status

John Quinn, Janet Glassford, Laura Percy, Philippa Munson, Teresa Marafioti, Manuel Rodriguez-Justo, Kwee Yong

Blood (2011) 117 (3): 890–901.

https://doi.org/10.1182/blood-2010-01-264424

Published: 2011

Includes: Supplemental data

Journal Articles

Induction of p53 and up-regulation of the p53 pathway in the human 5q− syndrome

Andrea Pellagatti, Teresa Marafioti, Jennifer C. Paterson, Jillian L. Barlow, Lesley F. Drynan, Aristoteles Giagounidis, Stefano A. Pileri, Mario Cazzola, Andrew N. J. McKenzie, James S. Wainscoat, Jacqueline Boultwood

Blood (2010) 115 (13): 2721–2723.

https://doi.org/10.1182/blood-2009-12-259705

Published: 2010

NARROW

Impact of Double Expression of MYC and BCL-2 on Outcomes in Primary CNS Lymphoma: A UK Multicentre Analysis

Anti-CD21 Chimeric Antigen Receptor (CAR)-T Cells for T Cell Acute Lymphoblastic Leukaemia (T-ALL)

Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress

Analysis of T-Cell Receptor Beta-Constant Region Expression for Rapid Assessment of T-Cell Clonality

Cytotoxic CD4+ Cells in Chronic Lymphocytic Leukaemia: An Extended Immunophenotypic Analysis Examining Their Association with Cytomegalovirus Serostatus and Similarities with Cytotoxic CD8+ Cells

Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial

ADCT-402, a PBD dimer–containing antibody drug conjugate targeting CD19-expressing malignancies

Acute Lymphoblastic Leukaemia (ALL) Cells and Commonly-Used Chemotherapy Drugs Can Induce Bone Marrow-Derived Mesenchymal Stromal Cells to Become Cancer Associated Fibroblasts (CAF), Leading to Enhanced ALL Proliferation and Treatment Resistance

Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation

Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA

VEGFA- a New Therapeutic Target in CNS Leukemia

Targeting T-Cell Receptor β-Constant Domain for Immunotherapy of T-Cell Malignancies

Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene

Mechanistic and Pharmacodynamic Studies of Adct-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies

A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy

The Ataxia Telangiectasia Nude Mouse with No Risk of Thymoma: A Model to Investigate Tumour Development of B Cell and Myeloid Origin Associated with ATM Loss

Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets

Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS

APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status

Induction of p53 and up-regulation of the p53 pathway in the human 5q− syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only